AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2019
Jun 19, 2019
35124_dirs_2019-06-19_2a853e09-33df-4b11-aee0-a36d2ca96e81.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2019-06-19
Reporting Person: CHURCH JEFFREY WAYNE (CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-06-19 | Celsion Corporation Common Stock | P | 5000 | $1.89 | Acquired | 7298 | Direct |
Footnotes
F1: The shares were purchased on the open market.
More from Imunon, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Feb 18